SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5573934

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.72

110068.55

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.61

Back

simplex papers ltd

Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter

Feb 12,2026

Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	53.81	56.17	-4
OPM %	11.43	15.54	-
PBDT	6.53	9.06	-28
PBT	5.60	8.25	-32
NP	4.43	5.96	-26

74,563.92 -1,470.50 ( -1.93%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)